Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia-Reference-Cited by-同舟云学术

Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia

Published:2015-02-09 Issue:1 Volume:6 Page:
ISSN:1757-6512
Container-title:Stem Cell Research & Therapy
language:en
Short-container-title:Stem Cell Res Ther

Author:

McLean Alison K,Stewart Cameron,Kerridge Ian

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)

Link

https://link.springer.com/content/pdf/10.1186/s13287-015-0047-8.pdf

Reference71 articles.

1. National Health and Medical Research Council. Stem Cell Treatments: A Quick Guide for Medical Practitioners. Canberra, Australia: National Health and Medical Research Council, Commonwealth of Australia, Canberra; 2013.

2. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–26.

3. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation. 2012;126:551–68.

4. Boncoraglio GB, Bersano A, Candelise L, Reynolds BA, Parati EA. Stem cell transplantation for ischemic stroke. Cochrane Database Syst Rev. 2010;9:CD007231.

5. Bura A, Planat-Benard V, Bourin P, Silvestre JS, Gross F, Grolleau JL, et al. Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy. 2014;16:245–57.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical use of autologous cell-based therapies in an evolving regulatory landscape: A survey of patient experiences and perceptions;F1000Research;2024-08-27

2. US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era;Cytotherapy;2024-04

3. The Evolution and Future Trends of Stromal Vascular Fraction: A Bibliometric Analysis;Tissue Engineering Part C: Methods;2024-04-01

4. Safety and efficacy claims made by US businesses marketing purported stem cell treatments and exosome therapies;Regenerative Medicine;2023-10

5. Clinical use of autologous cell-based therapies in an evolving regulatory landscape: A survey of patient experiences and perceptions;F1000Research;2023-09-18